• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠心病的遗传风险、动脉粥样硬化的特征和冠状动脉斑块负担。

Genetic Risk of Coronary Artery Disease, Features of Atherosclerosis, and Coronary Plaque Burden.

机构信息

Department of Cardiology Aarhus University Hospital Aarhus Denmark.

Department of Internal Medicine Horsens Regional Hospital Horsens Denmark.

出版信息

J Am Heart Assoc. 2020 Feb 4;9(3):e014795. doi: 10.1161/JAHA.119.014795. Epub 2020 Jan 25.

DOI:10.1161/JAHA.119.014795
PMID:31983321
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7033858/
Abstract

Background Polygenic risk scores (PRSs) based on risk variants from genome-wide association studies predict coronary artery disease (CAD) risk. However, it is unknown whether the PRS is associated with specific CAD characteristics. Methods and Results We consecutively included 1645 patients with suspected stable CAD undergoing coronary computed tomography angiography. A multilocus PRS was calculated as the weighted sum of CAD risk variants. Plaques were evaluated using an 18-segment model and characterized by stenosis severity and composition (soft [0%-19% calcified], mixed-soft [20%-49% calcified], mixed-calcified [50%-79% calcified], or calcified [≥80% calcified]). Coronary artery calcium score and segment stenosis score were used to characterize plaque burden. For each standard deviation increase in the PRS, coronary artery calcium score increased by 78% (=4.1e-26) and segment stenosis score increased by 16% (=2.4e-29) in the fully adjusted model. The PRS was associated with a higher prevalence of obstructive plaques (odds ratio [OR: 1.78, =5.6e-16), calcified (OR: 1.69, =6.5e-17), mixed-calcified (OR: 1.67, =7.3e-9), mixed-soft (OR: 1.45, =1.6e-6), and soft plaques (OR: 1.49, =2.5e-6), and a higher prevalence of plaque in each coronary vessel (all <1.0e-4). However, when analyzing data on a plaque level (3007 segments with plaque in 849 patients) the PRS was not associated with stenosis severity, plaque composition, or localization (all >0.05). Conclusions Our results suggest that polygenic risk based on large genome-wide association studies increases CAD risk through an increased burden of coronary atherosclerosis rather than promoting specific plaque features. Clinical Trial Registration URL: https://www.clinicaltrials.gov. Unique identifier: NCT02264717.

摘要

背景

基于全基因组关联研究中风险变异的多基因风险评分(PRSs)可预测冠心病(CAD)风险。然而,尚不清楚 PRS 是否与特定 CAD 特征相关。

方法和结果

我们连续纳入了 1645 例疑似稳定型 CAD 行冠状动脉计算机断层扫描血管造影的患者。多基因 PRS 作为 CAD 风险变异的加权和计算。使用 18 节段模型评估斑块,并通过狭窄严重程度和组成(软斑块[0%-19%钙化]、混合软斑块[20%-49%钙化]、混合钙化斑块[50%-79%钙化]或钙化斑块[≥80%钙化])进行特征描述。冠状动脉钙评分和节段狭窄评分用于评估斑块负担。在完全调整模型中,PRS 每增加一个标准差,冠状动脉钙评分增加 78%(=4.1e-26),节段狭窄评分增加 16%(=2.4e-29)。PRS 与更高比例的阻塞性斑块(比值比[OR]:1.78,=5.6e-16)、钙化斑块(OR:1.69,=6.5e-17)、混合钙化斑块(OR:1.67,=7.3e-9)、混合软斑块(OR:1.45,=1.6e-6)和软斑块(OR:1.49,=2.5e-6)相关,且每支冠状动脉的斑块发生率均较高(均<1.0e-4)。然而,当在斑块水平上进行数据分析(849 例患者中有 3007 个斑块节段)时,PRS 与狭窄严重程度、斑块成分或定位均无相关性(均>0.05)。

结论

我们的结果表明,基于大型全基因组关联研究的多基因风险通过增加冠状动脉粥样硬化负担而不是促进特定斑块特征来增加 CAD 风险。

临床试验注册网址

https://www.clinicaltrials.gov。

独特识别码

NCT02264717。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1907/7033858/0e5439653f52/JAH3-9-e014795-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1907/7033858/5edbedf0bc43/JAH3-9-e014795-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1907/7033858/a35e53d27536/JAH3-9-e014795-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1907/7033858/0e5439653f52/JAH3-9-e014795-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1907/7033858/5edbedf0bc43/JAH3-9-e014795-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1907/7033858/a35e53d27536/JAH3-9-e014795-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1907/7033858/0e5439653f52/JAH3-9-e014795-g003.jpg

相似文献

1
Genetic Risk of Coronary Artery Disease, Features of Atherosclerosis, and Coronary Plaque Burden.冠心病的遗传风险、动脉粥样硬化的特征和冠状动脉斑块负担。
J Am Heart Assoc. 2020 Feb 4;9(3):e014795. doi: 10.1161/JAHA.119.014795. Epub 2020 Jan 25.
2
Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction: Results From the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the HEART).冠状动脉计算机断层扫描血管造影中的低衰减非钙化斑块可预测心肌梗死:来自多中心 SCOT-HEART 试验(苏格兰心脏计算机断层扫描)的结果。
Circulation. 2020 May 5;141(18):1452-1462. doi: 10.1161/CIRCULATIONAHA.119.044720. Epub 2020 Mar 16.
3
Coronary Plaque Burden and Adverse Plaque Characteristics Are Increased in Healthy Relatives of Patients With Early Onset Coronary Artery Disease.健康的早发冠心病患者的亲属中,冠状动脉斑块负担和不良斑块特征增加。
JACC Cardiovasc Imaging. 2017 Oct;10(10 Pt A):1128-1135. doi: 10.1016/j.jcmg.2016.10.014. Epub 2017 Jan 18.
4
Non obstructive high-risk plaque but not calcified by coronary CTA, and the G-score predict ischemia.非阻塞性高危斑块但冠脉 CTA 未见钙化,以及 G 评分预测缺血。
J Cardiovasc Comput Tomogr. 2019 Nov-Dec;13(6):305-314. doi: 10.1016/j.jcct.2019.01.010. Epub 2019 Jan 4.
5
Relationship of coronary artery plaque composition to coronary artery stenosis severity: results from the prospective multicenter ACCURACY trial.冠状动脉斑块成分与冠状动脉狭窄严重程度的关系:前瞻性多中心 ACCURACY 试验结果。
Atherosclerosis. 2011 Dec;219(2):573-8. doi: 10.1016/j.atherosclerosis.2011.05.032. Epub 2011 May 31.
6
Polygenic Risk Score-Enhanced Risk Stratification of Coronary Artery Disease in Patients With Stable Chest Pain.多基因风险评分增强稳定型胸痛患者冠状动脉疾病的风险分层。
Circ Genom Precis Med. 2021 Jun;14(3):e003298. doi: 10.1161/CIRCGEN.120.003298. Epub 2021 May 25.
7
Differences in coronary plaque composition by noninvasive computed tomography angiography in individuals with and without obstructive coronary artery disease.通过无创性计算机断层血管造影术观察有和无阻塞性冠状动脉疾病个体的冠状动脉斑块组成差异。
Atherosclerosis. 2011 Mar;215(1):90-5. doi: 10.1016/j.atherosclerosis.2010.07.058. Epub 2010 Aug 19.
8
Comparative effectiveness of coronary artery stenosis and atherosclerotic plaque burden assessment for predicting 30-day revascularization and 2-year major adverse cardiac events.冠状动脉狭窄与动脉粥样硬化斑块负荷评估对预测 30 天血运重建和 2 年主要不良心脏事件的比较效果。
Int J Cardiovasc Imaging. 2020 Dec;36(12):2365-2375. doi: 10.1007/s10554-020-01851-3. Epub 2020 May 2.
9
The additive effect of essential hypertension on coronary artery plaques in type 2 diabetes mellitus patients: a coronary computed tomography angiography study.原发性高血压对 2 型糖尿病患者冠状动脉斑块的附加作用:一项冠状动脉 CT 血管造影研究。
Cardiovasc Diabetol. 2022 Jan 4;21(1):1. doi: 10.1186/s12933-021-01438-9.
10
Incremental prognostic value of quantitative plaque assessment in coronary CT angiography during 5 years of follow up.冠状动脉CT血管造影定量斑块评估在5年随访期间的增量预后价值。
J Cardiovasc Comput Tomogr. 2016 Mar-Apr;10(2):97-104. doi: 10.1016/j.jcct.2016.01.007. Epub 2016 Jan 13.

引用本文的文献

1
Appraisal of multiple polygenic risk scores to estimate the risk of myocardial infarction and coronary artery lesions.评估多个多基因风险评分以估计心肌梗死和冠状动脉病变的风险。
Commun Med (Lond). 2025 Jul 1;5(1):264. doi: 10.1038/s43856-025-00981-w.
2
Genomic Drivers of Coronary Artery Disease and Risk of Future Outcomes After Coronary Angiography.冠状动脉疾病的基因组驱动因素与冠状动脉造影术后未来结局的风险
JAMA Netw Open. 2025 Jan 2;8(1):e2455368. doi: 10.1001/jamanetworkopen.2024.55368.
3
Tianxiangdan suppresses foam cell formation by enhancing lipophagy and reduces the progression of atherosclerosis.

本文引用的文献

1
The ABO locus is associated with increased platelet aggregation in patients with stable coronary artery disease.ABO 基因座与稳定性冠心病患者血小板聚集增加相关。
Int J Cardiol. 2019 Jul 1;286:152-158. doi: 10.1016/j.ijcard.2019.01.090. Epub 2019 Feb 11.
2
Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.全基因组关联分析显示,良性前列腺增生与 PSA 血清水平存在遗传相关性。
Nat Commun. 2018 Nov 8;9(1):4568. doi: 10.1038/s41467-018-06920-9.
3
Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults: Implications for Primary Prevention.
天香丹通过增强脂质自噬抑制泡沫细胞形成,并减轻动脉粥样硬化进展。
In Vitro Cell Dev Biol Anim. 2025 Mar;61(3):298-310. doi: 10.1007/s11626-024-01004-z. Epub 2025 Jan 14.
4
Polygenic Risk Scores and Extreme Coronary Artery Calcium Phenotypes (CAC=0 and CAC≥1000) in Adults ≥75 Years Old: The ARIC Study.多基因风险评分与≥75 岁成年人的极重度冠状动脉钙表型(CAC=0 和 CAC≥1000):ARIC 研究。
Circ Cardiovasc Imaging. 2024 Nov;17(11):e016377. doi: 10.1161/CIRCIMAGING.123.016377. Epub 2024 Nov 13.
5
Polygenic Risk Is Associated With Long-Term Coronary Plaque Progression and High-Risk Plaque.多基因风险与长期冠状动脉斑块进展及高危斑块相关。
JACC Cardiovasc Imaging. 2024 Dec;17(12):1445-1459. doi: 10.1016/j.jcmg.2024.06.015. Epub 2024 Aug 14.
6
Polygenic Risk and Coronary Artery Disease Severity.多基因风险与冠状动脉疾病严重程度。
Circ Genom Precis Med. 2024 Oct;17(5):e004470. doi: 10.1161/CIRCGEN.123.004470. Epub 2024 Aug 8.
7
Use of Machine Learning for the Identification and Validation of Immunogenic Cell Death Biomarkers and Immunophenotypes in Coronary Artery Disease.利用机器学习识别和验证冠状动脉疾病中的免疫原性细胞死亡生物标志物和免疫表型
J Inflamm Res. 2024 Jan 12;17:223-249. doi: 10.2147/JIR.S439315. eCollection 2024.
8
Clinical applications of polygenic risk score for coronary artery disease through the life course.通过整个生命周期评估多基因风险评分在冠心病中的临床应用。
Atherosclerosis. 2023 Dec;386:117356. doi: 10.1016/j.atherosclerosis.2023.117356. Epub 2023 Oct 18.
9
Danish study of Non-Invasive Testing in Coronary Artery Disease 3 (Dan-NICAD 3): study design of a controlled study on optimal diagnostic strategy.丹麦非侵入性冠状动脉疾病检测研究 3 期(Dan-NICAD 3):一项关于最佳诊断策略的对照研究的设计方案。
Open Heart. 2023 Jul;10(2). doi: 10.1136/openhrt-2023-002328.
10
DanMAC5: a browser of aggregated sequence variants from 8,671 whole genome sequenced Danish individuals.DanMAC5:一个从 8671 个全基因组测序的丹麦个体中聚合序列变体的浏览器。
BMC Genom Data. 2023 May 27;24(1):30. doi: 10.1186/s12863-023-01132-7.
对 480,000 名成年人的冠心病的基因组风险预测:对一级预防的影响。
J Am Coll Cardiol. 2018 Oct 16;72(16):1883-1893. doi: 10.1016/j.jacc.2018.07.079.
4
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations.全基因组多基因疾病风险评分可识别出与单基因突变风险相当的个体。
Nat Genet. 2018 Sep;50(9):1219-1224. doi: 10.1038/s41588-018-0183-z. Epub 2018 Aug 13.
5
Diagnosing coronary artery disease after a positive coronary computed tomography angiography: the Dan-NICAD open label, parallel, head to head, randomized controlled diagnostic accuracy trial of cardiovascular magnetic resonance and myocardial perfusion scintigraphy.冠状动脉 CT 血管造影阳性后的冠状动脉疾病诊断:心血管磁共振与心肌灌注闪烁显像的丹-NICAD 开放标签、平行、头对头、随机对照诊断准确性试验。
Eur Heart J Cardiovasc Imaging. 2018 Apr 1;19(4):369-377. doi: 10.1093/ehjci/jex342.
6
Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease.64 个新的遗传位点的鉴定为冠心病的遗传结构提供了更广泛的视角。
Circ Res. 2018 Feb 2;122(3):433-443. doi: 10.1161/CIRCRESAHA.117.312086. Epub 2017 Dec 6.
7
Relationship of Hypertension to Coronary Atherosclerosis and Cardiac Events in Patients With Coronary Computed Tomographic Angiography.冠状动脉计算机断层血管造影患者中高血压与冠状动脉粥样硬化及心脏事件的关系
Hypertension. 2017 Aug;70(2):293-299. doi: 10.1161/HYPERTENSIONAHA.117.09402. Epub 2017 Jun 12.
8
FlashPCA2: principal component analysis of Biobank-scale genotype datasets.FlashPCA2:生物样本库规模基因型数据集的主成分分析
Bioinformatics. 2017 Sep 1;33(17):2776-2778. doi: 10.1093/bioinformatics/btx299.
9
A genetic risk score predicts cardiovascular events in patients with stable coronary artery disease.遗传风险评分可预测稳定型冠状动脉疾病患者的心血管事件。
Int J Cardiol. 2017 Aug 15;241:411-416. doi: 10.1016/j.ijcard.2017.04.045. Epub 2017 Apr 19.
10
Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting.多基因风险评分可识别出在一级预防中动脉粥样硬化负担更高且从他汀类药物治疗中获得更大相对获益的亚组。
Circulation. 2017 May 30;135(22):2091-2101. doi: 10.1161/CIRCULATIONAHA.116.024436. Epub 2017 Feb 21.